REVOLO BIOTHERAPEUTICS
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing and without suppression of the immune system. Its mission is to revolutionize autoimmune and allergic disease treatment by resetting the immune system for superior long-term disease remission. Revolo Biotherapeutics was founded in 2011 and formerly known as Immune Regulation.
REVOLO BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2011-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.revolobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
52.05 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA V2 Digital Ocean Gandi.net DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Investors List
24 Haymarket
24 Haymarket investment in Series B - Revolo Biotherapeutics
Metellus
Metellus investment in Series B - Revolo Biotherapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Revolo Biotherapeutics
24 Haymarket
24 Haymarket investment in Series A - Revolo Biotherapeutics
NCL Technology Ventures
NCL Technology Ventures investment in Series A - Revolo Biotherapeutics
Key Employee Changes
Date | New article |
---|---|
2020-03-27 | Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer |
Official Site Inspections
http://www.revolobio.com Semrush global rank: 4.44 M Semrush visits lastest month: 2.48 K
- Host name: revbio.wpmudev.host
- IP address: 95.179.200.140
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1